Systematic Review with Network Meta-Analysis: Antidiabetic Medication and Risk of Hepatocellular Carcinoma

Antidiabetic medication may modify the incidence of hepatocellular carcinoma (HCC). We aimed to compare the use of different antidiabetic strategies and the incidence of HCC. PubMed, Embase.com and Cochrane Library databases were searched up to 31 October 2015 and randomized controlled trials (RCTs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yao-Yao, Zhu, Gui-Qi, Liu, Tian, Zheng, Ji-Na, Cheng, Zhang, Zou, Tian-Tian, Braddock, Martin, Fu, Shen-Wen, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027387/
https://www.ncbi.nlm.nih.gov/pubmed/27642100
http://dx.doi.org/10.1038/srep33743

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027387/
https://www.ncbi.nlm.nih.gov/pubmed/27642100
http://dx.doi.org/10.1038/srep33743

Ejemplares similares